By: Jessica Hamlin
The pharmaceutical services industry has attracted billions of dollars from private equity investors over the years.
Jessica Hamlin is a Senior Reporter specializing in private equity at Institutional Investor. She covers a range of topics including finance, investment, and technology, with a particular focus on private equity markets and the evolving landscape of cryptocurrency. Her insights and analyses have been featured in prominent publications such as Institutional Investor, Morningstar, and PitchBook Data.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Jessica's coverage is heavily focused on the private equity sector, particularly on investment analysis and data-backed insights. She frequently cites data to support her articles and provides in-depth analysis of various investment trends.
Given Jessica's emphasis on citing data and providing investment analysis, she would likely be interested in pitches that offer unique access to proprietary or exclusive industry data, as well as expert commentary from individuals with a deep understanding of the private equity landscape.
Furthermore, Jessica's focus within finance & economy suggests that she may also be receptive to pitches related to endowments and impact investing within the context of private equity. If you have expertise or unique insights into these areas, it could make for a compelling pitch.
This information evolves through artificial intelligence and human feedback. Improve this profile .